Renée Fleming, Opera Great and Multi-Grammy Winner, Visits Wartburg

Renée Fleming with Registrants

LtoR: Renée Fleming, David J. Gentner, Dr. Connie Tomaino

MT. VERNON, NEW YORK, USA, August 16, 2018 / — Contact: Angela Ciminello

Opera Great and Multi–Grammy Winner, Renée Fleming visits Wartburg

Mount Vernon, NY, August 13, 2018 – Wartburg, Westchester’s premier provider of comprehensive residential and healthcare services for seniors, hosted the Tony-nominated Broadway star of Carousel, Renée Fleming. Wartburg President & CEO, David J. Gentner, the Institute for Music and Neurologic Function Executive Director Dr. Concetta Tomaino, Wartburg board member, Ulrich J. Rosa, and other senior staff met with Ms. Fleming in an effort to highlight the importance of music and arts on Wartburg’s campus.

“It was a joy to visit Wartburg – with the natural beauty of the campus and comprehensive care, its residents must feel at ease and at home.” Fleming said. “Understanding that integrating the arts greatly enhances quality of life and provides many cognitive and social benefits is especially powerful. I look forward to following the groundbreaking work of the Institute of Music and Neurologic Function, led by Dr. Connie Tomaino, as it continues the scientific exploration of the power of music therapy to awaken, stimulate, and heal the brain.”

While at Wartburg, Ms. Fleming visited the Adult Day Services program and was greeted by registrants singing as piano music filled the room. Additionally, she learned about the innovative music therapy services offered by the Institute for Music and Neurologic Function (IMNF) and Wartburg’s award-winning, internationally recognized arts-based therapy program, Creative Aging & Lifelong Learning. She also visited Wartburg’s Outpatient Center to hear about innovative programs using music to improve mobility and speech impairments.

IMNF Executive Director and Co-Founder, Dr. Concetta M. Tomaino said, “It was an honor to have Ms. Fleming visit IMNF at its new home at Wartburg. We are so grateful for her advocacy of the importance of music and brain health and happy she was able to see our work first hand.”

Ms. Fleming is a world renowned Soprano and four-time Grammy Award winner. In 2013, then President Obama awarded her the National Medal of Arts, America's highest honor for an individual artist. Ms. Fleming is a longtime advocate for the transformative power of music, including its therapeutic uses for individuals with neurologic issues. In 2016, she initiated a partnership between the National Institute for Health and the John F. Kennedy Center for the Performing Arts focusing on the intersections of music and the brain and is a spokesperson for the American Music Therapy Association.

Wartburg President, David J. Gentner shared, “Wow, what a thrill to welcome a legend to the campus. Ms. Fleming’s beliefs about the value of music and the arts in society are well documented so we were delighted that she would find the time to visit with Dr. Tomaino.”
Fleming’s visit ended with President Gentner reading a proclamation making Ms. Fleming an honorary member of the Wartburg family.

Wartburg, located in Westchester County, NY, offers integrated, comprehensive senior residential and healthcare services. Unlike conventional retirement communities, Wartburg provides a wide range of services to both residents living on its beautiful 34-acre campus and people in their own homes. From independent, assisted living and award-winning nursing home care to inpatient/outpatient rehabilitation, home care and adult day care services, its continuing care approach has earned Wartburg a trusted reputation in Westchester. Wartburg also provides caregiver support at every stage with an array of options to find the level of care that considers the whole family. Most recently, Wartburg was named one of the "Best Nursing Homes in New York State" by U.S. News & World Report for the eighth consecutive year in 2018. In addition, Wartburg received the 2016 Eli Pick Facility Leadership Award from the American College of Health Care Administrators and the 2015 Legacy Award from the Westchester County Chapter of the Links

Wartburg Website Homepage:
Wartburg Facebook Page:
Wartburg Twitter Page:
YouTube Page:

Angela Ciminello, Vice President of Development & Marketing
email us here

Source: EIN Presswire

California Verdict Sets Significant Precedent for RoundUp Lawsuits

A California court verdict has set a massive precedent for the cases brought against Monsanto. Lerner and Rowe Injury Attorneys is currently accepting cases.

Mega corporations like Monsanto are notoriously intimidating to go against on your own. We want to make sure that you don’t get bullied into submission. They have to be held accountable.”

— Kevin Rowe

PHOENIX, ARIZONA, US, August 16, 2018 / — At the end of last week, a California court reached a verdict that many believe has set a massive precedent of expectations for the continued wave of cases brought against Monsanto and it’s weed-killing product RoundUp. After deliberating for three days, a jury concluded that Dewayne Johnson’s use of RoundUp as a regular part of his former job as a school groundskeeper was responsible for the terminal cancer he developed. The court ordered Monsanto, the company that manufactures and distributes RoundUp, to pay Johnson $39 million for his suffering and a further $250 million in punitive damages. Our team at Lerner and Rowe Injury Attorneys is currently accepting and reviewing cases to represent you if you or a loved one was injured at the hands of Monsanto and RoundUp.

Links to Cancer

RoundUp has been thought to cause cancer, specifically non-Hodgkin's lymphoma, in a number of its users for years. Despite these claims, Monsanto has stood by and defended RoundUp’s safety for continued use. The company frequently cites studies that claim that glyphosate, the main weed-killing ingredient in RoundUp, isn’t immediately carcinogenic to humans. Yet, lawsuits against the product appear to focus more on the negative effects of the entire chemical solution, as opposed to the single ingredient.

Dewayne Johnson’s case was the first to reach trial, expedited by the terminal nature of his disease, and has set the tone for the remaining cases against the company. According to CNN, more than 800 patients are currently in the process of bringing cases against Monsanto that claim Roundup led to their developing cancer.

Monsanto is Standing by Their Product

Even after this monumental verdict, Monsanto continues to defend the safety of RoundUp and plans to continue to fight against these allegations. Following the decision, Monsanto’s Vice President Scott Partridge released a statement saying, “We will appeal this decision and continue to vigorously defend this product, which has a 40-year history of safe use and continues to be a vital, effective and safe tool for farmers and others."

If you, or someone you care about, were a user of RoundUp and developed non-Hodgkin’s lymphoma, or other cancers, as a result, please don’t hesitate to reach out to Lerner and Rowe Injury Attorneys. We will work together with you to form a plan of action to fight for your justly due compensation. Let us do the heavy lifting for you. “Mega corporations like Monsanto are notoriously intimidating to go against on your own. We want to make sure that you don’t get bullied into submission by a company that is trying to cover up their gross negligence. They have to be held accountable,” says personal injury attorney Kevin Rowe.

More about Lerner and Rowe

For additional information about Lerner and Rowe’s Phoenix personal injury attorneys call (602) 977-1900. To learn more about the criminal defense and bankruptcy legal services offered by their partner law firm Lerner and Rowe Law Group, visit or call (602) 667-7777. Need help filing an application or appeal for Social Security benefits? Contact the law firms other legal partners at Social Security Disability Advocates by calling (602) 952-3200 or online at

To connect with the law firm socially, follow Lerner and Rowe on Twitter, or become a fan of their Facebook page. Also visit to learn more about the community services that the lawyers and legal support team of Lerner and Rowe actively support.

Jim Rolshouse
Lerner & Rowe Injury Attorneys
email us here

Source: EIN Presswire

The New End of Life Doula Profession Merges with Health Care in Historic NYC Event

PDI Founders With NHPCO President Edo Banach

Leaders in The End of Life Doula Movement Come Together and Hold Inaugural Event in New York City September 27th – 30th

NEW YORK, NY, UNITED STATES, August 16, 2018 / — Hosted by Professional Doula International – a collaboration between Patty Burgess of Teaching Transitions/Doing Death Differently, Deanna Cochran RN of Quality of Life Care, and Suzanne O’Brien RN of The International Doulagivers Institute. This is an event especially for hospice, palliative care, comfort care, senior care and end-of-life doulas (or those who want to be!) to learn how to work within healthcare organizations who are beginning to embrace the utilization of doulas in their agencies. This weekend event will offer the NPEC Certification (National Professional End-of-Life Doula Certification) which is a specific healthcare focus, and it offers nursing CEs. The time has come for palliative and EOL doulas to take their rightful place alongside, and supporting mainstream healthcare.

(The “silver tsunami” in healthcare is upon us. The number of patients aging and needing palliative and end-of-life care is increasing at an alarming rate. Hospices are the only option for end-of-life care in this country other than personal caregivers. There are huge time and service limitations for hospices to serve this need.

Doulas are the bridge between the patient/family and healthcare agencies. EOL Doulas can serve in capacities that agencies cannot staff for at this time.

The newly formed NHPCO End of Life Doula Council and The National End of Life Doula Alliance (NEDA) have been created to establish this new progressive profession and also set the highest level of standards and scope of practice.

This training, led by US EOL doula trainers is designed to offer the highest level, and most relevant, current best practices for this doula role. You can use the 'NPEC' designation upon the successful completion of your NPEC Certification Weekend.

ABOUT PDI FOUNDERS: Deanna Cochran RN, Suzanne B. O'Brien RN , and Patty Burgess are all founding members of NHPCO'S End of Life Doula Council and Founding members of NEDA National End of Life Doula Alliance. Together, they bring more than 50 years of experience to the NPEC Training.

The NPEC conference is approved for 12 CE hours (nursing) and is co-provided by Home Care Institute, LLC. HCI is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Suzanne B. O'Brien RN
Professional Doula International
email us here

Source: EIN Presswire

Global Pharmacy Benefit Management Market (PBM) 2018 Analysis and Forecast to 2023 Research Report adds “Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers Regions Type and Application to 2023” report to its database.

PUNE, INDIA, August 16, 2018 / — adds “Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” new reports to its research database. The report spread across 133 pages with tables and figures in it.

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

This report focuses on the Pharmacy Benefit Management (PBM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pharmacy Benefit Management (PBM) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Order a purchase report copy of at .

Market Segment by Manufacturers, this report covers
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
Sea Rainbow

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquire before Buying at .

Market Segment by Type, covers
commercial health plans
self-insured employer plans
Medicare Part D plans
Federal Employees Health Benefits Program
state government employee plans

Market Segment by Applications, can be divided into
Mail-order Pharmacy Services
Non-mail Pharmacy Services

There are 15 Chapters to deeply display the global Pharmacy Benefit Management (PBM) market.
Chapter 1, to describe Pharmacy Benefit Management (PBM) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pharmacy Benefit Management (PBM), with sales, revenue, and price of Pharmacy Benefit Management (PBM), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmacy Benefit Management (PBM), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pharmacy Benefit Management (PBM) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pharmacy Benefit Management (PBM) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Get a Report Details at .

About Us: is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Contact Us
Mr. Jeet Jain
Sales Manager
+1-240-284-8070 / +44-20-3290-4151

Mr Jeet
Market Research Nest
email us here

Source: EIN Presswire

PetVivo Holdings, Inc. Moves Manufacturing Facility, Creates Research and Development Laboratory.

(All Press Releases Will Be Available for Viewing on Facebook or the Web at )


(OTCMARKETS: PETV), PetVivo Holdings, Inc. ( an emerging biomedical device company, is pleased to announce the moving of its manufacturing facility and the creation of a research and development lab.

In an effort to expand manufacturing and create a research and development facility, Petvivo, Inc. moved from Elite Solutions in Rochester, Minnesota to the home of CytoMedical Design Group LLC (cmdg) in St. Paul, Minnesota. The location has far better access for Petvivo employees and eliminates the costs of hotels and mileage which the company has been absorbing sending and supporting staff from Minneapolis for weeks at a time to work in Rochester.

“We estimate that our cost of manufacturing will be reduced substantially. It is also time to address our plan to continue improving our product and initiate our research and development plans. Assistance for both manufacturing and research will be available from staff members of the cmdg group. Cmdg has additional clean rooms and square footage for our use “commented Wes Hayne, CEO of Petvivo Holdings, Inc.

The move was performed in one week, coordinated with three different moving companies. Each company specializing in specific equipment, with different degrees of sensitivity. The move is now complete, and production is expected to resume within the next three weeks. The new surroundings and extra space will help in building the efficiencies of the manufacturing process.

About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCPINK: PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. PetVivo is leveraging investments made in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.
PetVivo's strategy is to commercialize proprietary products from human medical device companies specifically for the companion animal market. The company’s product pipeline includes seventeen animal and human therapeutics. A portfolio of twenty patents protects the company’s products, production processes and biomaterials. PetVivo’s lead product, a veterinarian-administered joint injection for the treatment of osteoarthritis in dogs, is scheduled for launch later this year.
Forward-Looking commercial Statements:
The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements.

Wes Hayne
Petvivo Holdings Inc
email us here

Source: EIN Presswire

One Stop Bedwetting Launches Expanded Redesigned Website Providing Unprecedented Access to Bedwetting Solutions

One Stop Bedwetting, a leading provider of bedwetting alarms has launched a revolutionary new website making it easier to shop for incontinence solutions.

SANTA CLARA, CA, USA, August 16, 2018 / — One Stop Bedwetting, a leading provider of bedwetting alarm, waterproof mattress pads, vibrating watches and incontinence products, announced today the launch of it new, redesigned responsive website – The new website will expand the One Stop Bedwetting portfolio of bedwetting solutions and enhanced customer support. It also captures the corporate values of the company and its achievements with the use of live customer chat and product videos.

The website redesign includes aesthetic enhancements to provide a more engaging user experience and enhanced navigation to help visitors easily find the information they need. Customers can browse the large selection of products, and subscribe to a biweekly bedwetting blog and get discount coupons and promotions delivered in their inbox.
The site features a brand new resource center specially written by bedwetting specialists to provides visitors with exclusive enhanced content and gives them a better understanding of the bedwetting, its treatment and solutions. The collection of articles is especially targeted to educate the millions of individuals who suffer from nocturnal enuresis.
Visitors get handy practical tips for dealing with bedwetting and will have the opportunity to watch on demand videos, download user manuals and exchange emails with specialists. The website has a new section devoted to product reviews and testimonials for visitors to read and share opinions and make the right choice selecting a bedwetting alarm.
The company also announced that effective immediately, all domestic customers will get free shipping on purchase of any bedwetting alarm and bedwetting kits and avail unlimited access to bedwetting specialists. Customers can save up to 25% on already low prices of select bedwetting kits when ordered online.

According to a company spokesperson, “We are thrilled and proud to debut our new company website to our customers, doctors, partners and visitors who are looking to understand our products and services. This website redesign is truly another way we are committed to creating the best possible experience for our customers. We are certain that the redesign will reinforce One Stop Bedwetting as a leading provider of bedwetting alarms, waterproof mattress pads and bedwetting solutions. With the new design, we expect an increase in website visitors and content consumption. We look forward to feedback and the exciting new developments to come.”

The company’s award winning products are widely recommended by pediatricians to stop nighttime bedwetting. The website features a complete assortment of wearable and bedside bedwetting alarms from popular brands including Chummie, Smart, Shield, Guardian, NewU and Zest, waterproof mattress pads from Prisma and potty training solutions from Joy.
“One of the many exciting new website features launched in early August was multi-currency order processing. This will be particularly beneficial for our large number of international customers who will not only be able to view product prices in their own currency but will also be able to pay using their local credit/debit cards without having to convert to US dollars. International customers will not be charged a currency exchange fee and the price they see is exactly the price they pay! Shipping costs and delivery times are calculated dynamically at the time of checkout.” said a company representative.

The revamped website also features an updated look with enhanced features, including easier navigation, product search, improved overall usability, updated information and a much requested bedwetting alarm finder tool. Designed by specialists, the alarm finder tool eliminates the confusion visitors often experience shopping for a bedwetting alarm. Visitors answer a few quick questions related to their sleeping habits and gender and the tool presents the right bedwetting alarm. Visitors are encouraged to explore the new website and sign up for the One Stop Bedwetting mailing list to receive direct emails and discount coupons.

One Stop Bedwetting is a leading provider and one of the largest online store of quality bedwetting alarms, waterproof mattress pads, vibrating watches and bedwetting solutions for children, teens and adult bed wetters. Headquartered in Santa Clara, CA, One Stop Bedwetting and its products are widely recommended by pediatricians to stop bedwetting. The company offers hundreds of solutions sourced directly from manufacturers at deep discount and passes those savings to its consumers. For more information, please visit

Elizabeth Parker
One Stop Bedwetting
email us here

Source: EIN Presswire

Global Digital Orthodontics Market is expected to grow at CAGR of 18%

Global Digital Orthodontics Market is expected to grow at CAGR of 18% and to reach a revenue of $6.20 Billion by 2023

HYDERABAD, TELANGANA, INDIA, August 16, 2018 / — In the Report “Digital Orthodontics Market: By imaging technology (X-rays, lasers, white light, 3D impressions, 3d imaging); By Technology (digital photography, intraoral scanners, 3D printers, others); By end use (hospitals, clinics, research institutes, laboratories); By Geography – Forecast (2018-2023)” published by IndustryARC, the market is driven by increased production capacity and elimination of bulky model storage that has resulted in the higher adoption rate of these devices.

America leading with major share in the Digital Orthodontics Market

On a geographic level, American regions are the dominant player in the market with a 62% market share, with a large portion of it being held by the US, followed by Canada. America generated a revenue of $1.33 billion in 2017. The market for America is expected to grow at a CAGR of 16.6%, and to reach a value of $3.35 billion by 2023. The European region with its EU5 countries such as Germany, Spain and Italy, holds 25% market share. The European market is anticipated to grow at a CAGR of 19.3%, to reach a revenue of $1.67 billion by 2023. The APAC region will exhibit high growth rate of 21.5%, and is projected to be worth $946.88 million by 2023.

Selected Technology Analysis done in the full Report:

The global digital orthodontics market includes intraoral scanners, intraoral cameras and 3D printers. Among all, intraoral scanners account for majority of the revenue in the Global Digital Orthodontics market, contributing approximately 68%. The market for intraoral scanner is estimated to grow at a CAGR of 18.5% from $1534.2 million in 2017 to reach $4245.34 million by 2023. Growing disposable incomes, raising awareness of facial aesthetics and insurance coverage makes this market to grow at a higher rate. With the increasing attention to smile aesthetics and other Orthodontic procedures, Orthodontists across the globe use Intraoral Camera to devise the best treatment available for each patient. North America is the leading one in intraoral cameras togenerated revenueof $36.9 million in 2017, and is estimated to grow at a CAGR of 4% to reach $42.98 million by 2023. The 3D printers market is estimated to grow at a CAGR of 18.6% to reach $1671.80 million by 2023. Increase in production capacity, operational costs and faster model-making than hand milling is fuelling the growth of the market.

To access / purchase the full report browse the link below

Excerpts on Market Growth Factors

The start-ups are developing innovative, portable and affordable digital orthodontics systems including digital photography, CAD/CAM, intraoral digital scanners and 3D printers. Such companies developing products with innovative solutions might pose a mild threat to the existing companies since digital orthodontics is still in the growth stage.
Number of companies entering the digital orthodontics market is increasing the market attractiveness. The competition is moderate due to high customer loyalty for branded products. The launch of new products and on-going development is the major factor behind long term growth of this market.
Dental instrument is growing rapidly throughout the world due to ample reasons including low cost, high quality, shorter waiting time, convenient, travel opportunities, most importantly being a cost effective alternative to the dental care offered in their own country, which will ultimately lead to the increase in the demand of digital orthodontics procedures.

Talk to one of our sales representative about the full report by providing your details in the link below:

Key players of the Digital Orthodontics Market

The Digital Orthodontics Market comprises of numerous companies, catering to different requirements of the end-users.The digital orthodontics market is chiefly dominated by Sirona Dental Systems, Planmeca OY, Stratasys Ltd, 3Shape Systems, 3M Healthcare and Align Technology. However, the growing number of start-ups, coupled with technological advancements will shift the market share slightly from key players to smaller companies. Sirona Dental System’s major productCerec, Planmeca OY’s product PlanScan, Align Technology Inc. product iTero with the function of scanning and patented dual aperture lens system simultaneous capture 2D images in color with highly accurate 3D laser scanning, and last but not the least, Carestream Health’s launch of CS 3500 are some of the key products functioning towards the growth of the market.

Digital Orthodontics Market report is segmented as below

A. Digital Orthodontics Market – By Imaging technology

1. X-rays
2. Lasers
3. White light
4. 3D impressions
5. 3D imaging

B. Digital Orthodontics Market – By Technology

1. Digital Photography
2. Computer-Aided Design/Computer-Aided Manufacturing
3. Intraoral Scanners
4. 3D Printers

C. Digital Orthodontics Market – By Usage

1. Contrast Medium Dependent Scanner
2. Contrast Medium Independent Scanner

D. Digital Orthodontics Market – By End User Industry

1. Hospitals
2. Clinics/ASCs
3. Research Institutes
4. Laboratories

E. Digital Orthodontics Substrate Market – By Geography
F. Digital Orthodontics Market by Geography (covers 10+ countries)
G. Digital Orthodontics Market Entropy

Companies Cited / Interviewed

1. Ormco Corporation
2. Geodigm Corporation
3. Orametrix, Inc.
4. PlanemecaOy
5. Dental Wings Inc
6. Envisiontec, Inc.
7. Ios Technologies, Inc.
8. Biolase, Inc.
9. Durr Dental Ag
10. Densys 3d Ltd.
11. BegoGmbh& Co. Kg
12. Rf America Ids
13. Suni Medical Imaging, Inc.
14. Dexis, Llc.
15. Acteon Group
16. Eos Gmbh
17. Company 17
18. Company 18
19. Company 19
20. Company 20+

Related Report:

A. Dental Treatment Consumables Market

B. Dental Implants & Prosthetics Market

What can you expect from the report?

The Digital Orthodontics Market Report is Prepared with the Main Agenda to Cover the following 20 points:

1. Market Size by Product Categories & Application 11. Demand Analysis (Revenue & Volume)
2. Market trends & Relevant Market Data 12. Country level Analysis
3. Manufacturer Landscape 13. Competitor Analysis
4. Distributor Landscape 14. Market Shares Analysis
5. Pricing Analysis 15. Value Chain Analysis
6. Top 10 End user Analysis 16. Supply Chain Analysis
7. Product Benchmarking 17. Strategic Analysis
8. Product Developments 18. Current & Future Market Landscape Analysis
9. Mergers & Acquisition Analysis 19. Opportunity Analysis
10. Patent Analysis 20. Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC publish country or application based reports in Digital Orthodontics Market segment?
Response: Yes, we do have separate reports as mentioned below:

1. Americas Digital Orthodontics Market (2018-2023)
2. Asia Pacific Digital Orthodontics Market (2018-2023)
3. Europe Digital Orthodontics Market (2018-2023)
4. Imaging Technology Digital Orthodontics Market (2018-2023)
5. Technology Digital Orthodontics Market 2018-2023)
6. Usage Digital Orthodontics Market 2018-2023)
7. End-User Digital Orthodontics Market 2018-2023)

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interests.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:

Media Contact:

Mr. Venkat Reddy
Sales Manager
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences &Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications in a Market. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.

We look forward to support the client to be able to better address their customer needs, stay ahead in the market, become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
+1-614-588-8538 (Ext-101)
email us here

Source: EIN Presswire

Mental Health Watchdog Warns Officials on Baker Act Rights Abuses

Florida's Children at Risk

The headquarters for CCHR Florida are located in downtown Clearwater

The headquarters for CCHR Florida are located in downtown Clearwater

CCHR Florida

With reports stating that the number of citizens being Baker Acted is rising, CCHR is cautioning lawmakers to pay heed to the potential for misuse and abuse.

The number of Baker Acts where a person, especially a child, never met the criteria for an involuntary psychiatric examination is disturbingly high and we are demanding that something be done.”

— Diane Stein, President of CCHR Florida

CLEARWATER, FLORIDA, UNITED STATES, August 15, 2018 / — With reports surfacing that the number of citizens being Baker Acted is on the rise following the school shooting in Parkland, the Citizens Commission on Human Rights (CCHR) is cautioning those charged with executing an involuntary psychiatric examination to pay heed to the potential for misuse and abuse. [1]

During fiscal year 2015/2016 there were 194,354 involuntary Baker Act examinations in Florida. This figure is more than double the number of men, women and children who were Baker Acted during fiscal year 2001/2002 and is significantly more than the 21.80 percent change in Florida’s population over the same time period.

This alarming increase prompted CCHR, a mental health watchdog organization that investigates and exposes human rights violations in the mental health industry, to issue a warning to state officials on the abusive use of the Baker Act law as illustrated by hundreds of complaints received by CCHR from Floridians across the state.

“Prior to the tragedy in Parkland the number of Baker Acts was already skyrocketing and based on the complaints we receive on our hotline about 60% of the people being taken into custody and sent for an involuntary psychiatric examination never met the criteria for a Baker Act in the first place,” reported Diane Stein, President of the CCHR Florida chapter.

The Baker Act law lays out three criteria for the involuntary examination of a person and all three criteria must but met, yet CCHR has found that the majority of citizens and even those authorized to initiate a Baker Act don’t know or understand these criteria.

In response, CCHR Florida regularly hosts a seminar on Baker Act Rights delivered by attorney at law Carmen Miller who as a former assistant public defender has personal experience in representing Baker Act clients in civil and criminal hearings. During the seminar, Ms. Miller provides those in attendance with information on the Baker Act and on their rights under this law while answering questions on how a person can protect themselves from the abusive use of the mental health law. [2]

“Over the past few years we have participated in or hosted hundreds of events for the sole purpose of educating people on their rights and exposing abusive psychiatric practices such as the prescribing of dangerous drugs that have known side effects such as suicide, aggression and homicidal ideation,” said Stein. “Thomas Jefferson said that ‘an educated citizenry is a vital requisite for our survival as a free people’ and I believe it is CCHR’s duty to help make sure every Floridian understands their rights.” [3]

For more information on the next Baker Act Rights seminar please call 727-442-8820 or visit the center at 109 N. Fort Harrison Avenue, Clearwater, Florida.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969. For more information visit,


[1] Local Officials, Organizations are Seeing an Increase in Baker Act use in SWFL
[2] Voices for Humanity: A Stand for Rights in the Sunshine State
[3] Psychiatric Drugs: Create Violence and Suicide

Diane Stein
Citizens Commission on Human Rights of Florida
email us here

CCHR: What We Believe

Source: EIN Presswire

Antidepressant Addiction Called a Huge Uncontrolled Experiment

The headquarters for CCHR Florida are located in downtown Clearwater

The headquarters for CCHR Florida are located in downtown Clearwater

Antidepressants Kill

Antidepressants Kill

Over a million children under the age of six are currently on psychiatric drugs in America

Over a million children under the age of six are currently on psychiatric drugs in America

Hundreds of people reported wishing to stop antidepressants as they had been prescribed as a short-term solution. Long-term addiction was not part of the plan.

People need to know the truth about these dangerous drugs and demand true express and informed consent in which all potential side effects are disclosed and alternative solutions offered.”

— Diane Stein, President CCHR Florida

CLEARWATER, FLORIDA, UNITED STATES, August 15, 2018 / — Over 8,800 people responded to the New York Times in a follow-up to its April 8th article on antidepressant addiction. The article exposed the severe difficulties people have had in coming off anti-depressants, since the widespread introduction of these drugs in America. [1]

The original article, “Most People Taking Antidepressants Discover They Cannot Quit”, pointed out that while these drugs were originally researched and marketed for short-term periodic use, today 15.5 million Americans have been taking them for 5 years or more.

By the mid-1990’s, however, pharmaceutical companies convinced the government of the desirability of open-ended continuation of these drugs. “Marketers and some researchers implied that antidepressants corrected deficits in brain levels of serotonin, a neurotransmitter. In truth six decades of research into the chemical imbalance theory of depression and anxiety has not achieved scientific credibility. [2]

A further boost to the proliferation of psychiatric medications, noted in the Times article, was the government’s 1997 decision to allow drug makers to advertise directly to consumers. By promoting a rosy picture of medicated states to the general public on a daily basis, manufacturers were able to greatly expand the market for mind-altering prescription drugs. “Everyone knew someone taking them. Long-term prescription rates surged,” the article, states.

Those wishing to withdraw from such medications usually cite to unwanted side effects as the reason they want to stop, such as sexual dysfunction and weight gain. Kate Slattery of Orlando, Florida wanted to stop Efflexor due to pregnancy. “When I stopped cold turkey, I felt extremely unwell and had to go back on and wean off slowly…prevented the dizziness, headache and fogginess I felt when I originally stopped the medication.”

As a further extension of the problem, in 2000 doctors started prescribing antidepressants to children. Today, recent estimates from the National Center for Health Statistics estimate that 7.5 percent of children between the ages of 6 and 17 are on psychiatric medications. [3]

These developments have prompted new concerns. The Mayo Clinic now publishes a guidebook helping parents “learn why antidepressants have warnings about suicidal thinking in children and teens, what to do before your child starts taking an antidepressant, and the warning signs of a potential problem.” [4]

The Times article also quotes Emma Dreyfus of Boston, saying that being put on Paxil at age 10 for anxiety was the “one mistake her parents had made”. Only at 23 was she able to slowly get off the drug. “I don’t blame them, but I wish we’d all understood the long-term effects.”

Even more disturbing is the report from a study released in 2016. This study reviewed and analyzed 70 antidepressant clinical trials with patient narratives for more than 18,000 participants, concluded that antidepressants doubled the risk of aggression and suicide in children and teens. [5]

“People need to know the truth about these dangerous drugs and demand true express and informed consent in which all potential side effects are disclosed and alternative solutions offered when a psychiatric drug is recommended as treatment for any condition,” said Diane Stein, President of the Florida chapter of the Citizens Commission on Human Rights (CCHR).

For more information on antidepressants and other psychotropic medication please call 727-442-8820 or visit
About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. It was L. Ron Hubbard, the founder of Scientology, who brought the terror of psychiatric imprisonment to the notice of the world. In March 1969, he said, “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health.’”

[1] New York Times – Antidepressants and Withdrawal: Readers Tell Their Stories By BENEDICT CAREY APRIL 17, 2018
[2] Why Depression Isn’t Caused By Low Serotonin
[3] NIH Posts – Post by Former NIMH Director Thomas Insel: Are Children Overmedicated? June 6, 2014
[4] Mayo Clinic Staff, May 27, 2016
[5] Antidepressants Double the Risk of Aggression and Suicide in Children, Study Confirms
CCHR Bulletin.
CCHR Violence Report.

Diane Stein
Citizens Commission on Human Rights of Florida
email us here

CCHR: Drugging Children—Did You Know?

Source: EIN Presswire

Hardman Batchelor Places Jim Ramsey as Vice President, Americas Sales For National Instruments Corporation

Picture of Jim Ramsey

Jim Ramsey

Logo for Hardman Batchelor International

Hardman Batchelor International, a global retained executive search firm, completes Vice President Americas Sales search for National Instruments Corporation.

Jim Ramsey was a clear choice among a list of top national candidates given his relevant experience and admired reputation as a strong sales leader, mentor and coach.”

— Edward Batchelor, Managing Partner

AUSTIN, TEXAS, USA, August 15, 2018 / — Following a national search, global retained search firm Hardman Batchelor International has placed executive Jim Ramsey as the new Vice President, Americas Sales of National Instruments Corporation (NASDAQ: NADI) effective immediately. Headquartered in Austin, National Instruments develops and manufactures software and hardware products that engineers and scientists use for test, control and embedded design applications. In 2017, the company sold products to more than 35,000 companies with revenues of more than $1.29 billion and global operations across 50 countries. The search was led by Managing Partner, Edward Batchelor, software & technology practice leader of HBI.

Jim Ramsey brings over 30 years’ experience in sales and sales strategy, joining NI two and a half years ago to spearhead the Americas Partner strategy and team. Prior to NI, Jim spent most of his career at Maxim Integrated where he drove design influence across a $1 billion business achieving double-digit growth. In this Vice President of Sales for the Americas, he will have overall responsibility for the development and execution of the sales plan (representing 40% of the revenue of NI) with responsibility to increase the Company’s market share as well as capture new customers. He will also have dotted line responsibility for the regional marketing and operations functions partnered with the Americas region which are now centralized globally.

“Jim Ramsey was a clear choice among a list of top national candidates given his relevant experience and admired reputation as a strong sales leader, mentor and coach.” Mr. Batchelor said.

Hardman Batchelor also recently placed Paul Horton as Vice President, Global Operations at National Instruments Corporation. He brought a wealth of experience in Global Finance, Information Solutions and Sales Operations across General Motors, EDS, Hewlett Packard Enterprises Services and DXC Technology (CSC and HP Enterprises Merger). He most recently served as the Vice President of Global Sales Operations at DXC where he led project teams that designed the new company’s sales organization, processes and compensation.

About Hardman Batchelor International

Founded by former “Big Five Firm” Partner Edward Batchelor, Hardman Batchelor International is a groundbreaking global firm specializing in recruiting and assessing world-class Board Directors, CEOs and C-Level executives with a particular focus on confidential mandates and cultivating the underserved “Middle America” marketplace. The firm offers retained executive and board level search; reference checking; candidate benchmarking; and management assessment. It has been recognized as a 2018 Hunt Scanlon Global Talent Leader signifying quality, exceptional service and distinguished leadership in executive recruiting.

Edward Batchelor
Hardman Batchelor International
+1 512 761 3268
email us here

Source: EIN Presswire